Skip to main content

Table 2 Reduction of mean systolic blood pressure values at 6 and 12 weeks for each dose of olmesartan and amlodipine FDC

From: Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)

Olmesartan and amlodipine doses Baseline (mean ± SD) 6 weeks (mean ± SD) Difference initial/6 weeks (mean ± SD) p 12 weeks (mean ± SD) Difference initial/12 weeks (mean ± SD) p
20/5 mg (N = 183 patients) 157 ± 16.28 138.45 ± 14.10 18.76 ± 21.72 <0.001 129.24 ± 12.92 27.75 ± 20.73 <0.001
40/5 mg (N = 198 patients) 161.93 ± 17.92 140.85 ± 14.04 20.83 ± 22.64 <0.001 130.79 ± 10.77 31.13 ± 22.23 <0.001
40/10 mg (N = 47 patients) 176.46 ± 18.68 140 ± 12.88 36.68 ± 21.87 <0.001 129.5 ± 12.40 46.96 ± 20.15 <0.001
  1. N = 428 patients